HP INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (In millions) | |||||||
Three months ended | |||||||
October 31, 2019 | October 31, 2018 | ||||||
Cash flows from operating activities: | |||||||
Net earnings | $ | 388 | $ | 1,451 | |||
Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||||
Depreciation and amortization | 205 | 140 | |||||
Stock-based compensation expense | 64 | 65 | |||||
Restructuring and other charges | 134 | 40 | |||||
Deferred taxes on earnings | (192 | ) | (486 | ) | |||
Other, net | 78 | 85 | |||||
Changes in operating assets and liabilities, net of acquisitions: | |||||||
Accounts receivable | (739 | ) | (514 | ) | |||
Inventory | (44 | ) | (15 | ) | |||
Accounts payable | 85 | 519 | |||||
Taxes on earnings | 272 | (412 | ) | ||||
Restructuring and other | (32 | ) | (30 | ) | |||
Other assets and liabilities | 369 | 125 | |||||
Net cash provided by operating activities | 588 | 968 | |||||
Cash flows from investing activities: | |||||||
Investment in property, plant and equipment | (196 | ) | (187 | ) | |||
Proceeds from sale of property, plant and equipment | — | 62 | |||||
Purchases of available-for-sale securities and other investments | — | (47 | ) | ||||
Maturities and sales of available-for-sale securities and other investments | — | 259 | |||||
Collateral posted for derivative instruments | — | (24 | ) | ||||
Collateral returned for derivative instruments | — | 24 | |||||
Payment made in connection with business acquisitions, net of cash acquired
| (31 | ) | — | ||||
Net cash (used in) provided by investing activities | (227 | ) | 87 | ||||
Cash flows from financing activities: | |||||||
Payment of short-term borrowings with original maturities less than 90 days, net | — | (834 | ) | ||||
Payment of short-term borrowings with original maturities greater than 90 days | — | (412 | ) | ||||
Proceeds from debt, net of issuance costs | 33 | — | |||||
Payment of debt | (76 | ) | (39 | ) | |||
Stock-based award activities | (3 | ) | 18 | ||||
Repurchase of common stock | (461 | ) | (598 | ) | |||
Cash dividends paid | (236 | ) | (219 | ) | |||
Net cash used in financing activities | (743 | ) | (2,084 | ) | |||
Decrease in cash and cash equivalents | (382 | ) | (1,029 | ) | |||
Cash and cash equivalents at beginning of period | 4,919 | 6,195 | |||||
Cash and cash equivalents at end of period | $ | 4,537 | $ | 5,166 | |||